Senior Analyst - Financial Control, 6 month Fixed-Term Contract

About the role

We are seeking a Senior Analyst - Financial Control to join CSL's Corporate Finance team on a 6-month fixed-term contract. Your role sits within CSL Corporate and supports the entire CSL Enterprise, including CSL Behring, CSL Vifor, and CSL Seqirus. Reporting to the Senior Director, Financial Control, you will play a key role in maintaining financial policies, managing internal controls, and supporting statutory reporting across the group. You will support in the maintenance and enhancement of internal control frameworks and financial policies across CSL globally. You will assist with segregation of duties, access reviews for key finance systems and related risk mitigation activities. You will support the Group's internal management and control representation process, including coordination of monthly and bi-annual activities and summarising key outcomes to support timely and appropriate responses You will support enterprise-level financial risk identification, assessment, and mitigation strategies. You will help prepare half-year and year-end statutory financial statements, including audit coordination and support the maintenance of financial statement data within group reporting systems. You will collaborate with finance business partners, COEs, and external auditors to ensure accurate financial reporting and policy compliance. Your skills and experience Minimum 3 years' experience in financial controls, reporting, and accounting; experience with Big 4 firms and ASX-listed companies is highly desirable. Professional accounting qualification (CPA or CA) is required; a bachelor's degree in Accounting, Finance, or related discipline is necessary. Strong technical knowledge of AIFRS and ASX rules. Experience working with SAP GRC and managing internal control processes. Apply now to join Australia's largest Life Science organisation and an Australian success story! About CSL Behring CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/ .

Benefits

Your Match

How well this role fits your profile.

Company Intel

What employees say

Worked at CSL? Share your experience